Please use this identifier to cite or link to this item: https://olympias.lib.uoi.gr/jspui/handle/123456789/20465
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSoucacos, P. N.en
dc.contributor.authorBeris, A. E.en
dc.contributor.authorMalizos, K.en
dc.contributor.authorKoropilias, A.en
dc.contributor.authorZalavras, H.en
dc.contributor.authorDailiana, Z.en
dc.date.accessioned2015-11-24T19:07:45Z-
dc.date.available2015-11-24T19:07:45Z-
dc.identifier.issn0009-921X-
dc.identifier.urihttps://olympias.lib.uoi.gr/jspui/handle/123456789/20465-
dc.rightsDefault Licence-
dc.subjectAdolescenten
dc.subjectAdulten
dc.subjectArthroplasty, Replacement, Hip/methodsen
dc.subjectBone Transplantation/adverse effects/*methodsen
dc.subjectDisease Progressionen
dc.subjectFemaleen
dc.subjectFemur Head Necrosis/*radiography/*surgeryen
dc.subjectFibula/*blood supply/*transplantationen
dc.subjectFollow-Up Studiesen
dc.subjectGraft Rejectionen
dc.subjectGraft Survivalen
dc.subjectHumansen
dc.subjectMaleen
dc.subjectMiddle Ageden
dc.subjectPostoperative Complicationsen
dc.subjectRange of Motion, Articularen
dc.subjectReoperationen
dc.subjectRetrospective Studiesen
dc.subjectSeverity of Illness Indexen
dc.subjectTreatment Outcomeen
dc.titleTreatment of avascular necrosis of the femoral head with vascularized fibular transplanten
heal.typejournalArticle-
heal.type.enJournal articleen
heal.type.elΆρθρο Περιοδικούel
heal.identifier.secondaryhttp://www.ncbi.nlm.nih.gov/pubmed/11347825-
heal.languageen-
heal.accesscampus-
heal.recordProviderΠανεπιστήμιο Ιωαννίνων. Σχολή Επιστημών Υγείας. Τμήμα Ιατρικήςel
heal.publicationDate2001-
heal.abstractTwo hundred twenty-eight hips in 187 patients with avascular necrosis of the femoral head were treated with vascularized fibular transplant from March 1989 to March 2000. The etiologic factors associated with the disease included corticosteroids in 84 patients (44%; 101 hips, trauma in 25 patients (13%; 29 hips), alcohol abuse in 24 patients (12%; 28 hips), and 41 hips (18%) were classified as idiopathic. Systemic disorders, including systemic lupus erythematosus, sickle cell anemia, inflammatory bowel disease, pregnancy, and dysbaric disease were observed in 12, nine, four, three, and one hip(s), respectively. Of the 228 hips operated on, 184 hips (152 patients) were assessed postoperatively with followup ranging from 1 to 10 years (mean, 4.7 years). Using the Steinberg classification system, 39 hips (21%) were in Stage II; 45 hips (25%) were in Stage II; 77 hips (42%) were in Stage IV; and 23 hips (12%) were in Stage V. Of the 184 hips treated, 101 (54%) remained stable postoperatively, whereas 69 (38%) had progression, and 14 hips (8%) were converted to total hip arthroplasty. Of the 69 hips that had progression, 44 (64%) did not progress until 6 to 10 years after the procedure, whereas 25 (36%) progressed within the first 5 years postoperatively. The best results were obtained in patients with Stage II osteonecrosis in whom 95% of the hips did not progress postoperatively. In contrast, only 39% of the hips in patients with Stage V osteonecrosis remained stable. Preoperative and postoperative clinical evaluation using the Harris hip score showed an increase from 85 to 96 points in hips with Stage II disease; from 74 to 91 points in hips with Stage III disease; from 69 to 85 points in hips with Stage IV disease; and from 61 to 76 in hips with Stage V disease. The current results show that the vascularized fibular graft is an excellent procedure for the precollapse stages and a valuable alternative for patients with Stages III, IV, and V of the disease.en
heal.journalNameClin Orthop Relat Resen
heal.journalTypepeer-reviewed-
heal.fullTextAvailabilityTRUE-
Appears in Collections:Άρθρα σε επιστημονικά περιοδικά ( Ανοικτά) - ΙΑΤ

Files in This Item:
There are no files associated with this item.


This item is licensed under a Creative Commons License Creative Commons